RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 101 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $364,000 | -20.2% | 133,384 | -3.3% | 0.04% | -21.4% |
| Q1 2017 | $456,000 | +0.4% | 137,884 | -27.7% | 0.06% | -30.9% |
| Q4 2016 | $454,000 | -26.2% | 190,605 | +13.8% | 0.08% | -44.1% |
| Q3 2016 | $615,000 | +36.7% | 167,505 | -17.0% | 0.14% | +28.3% |
| Q2 2016 | $450,000 | -20.8% | 201,738 | -26.1% | 0.11% | -38.6% |
| Q1 2016 | $568,000 | +30.0% | 272,895 | +89.4% | 0.18% | -30.0% |
| Q4 2015 | $437,000 | – | 144,100 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 9,105,691 | $30,140,000 | 5.99% |
| Sio Capital Management, LLC | 1,888,181 | $6,250,000 | 3.50% |
| DAFNA Capital Management LLC | 473,478 | $1,567,000 | 1.32% |
| Cormorant Asset Management, LP | 2,000,000 | $6,620,000 | 0.96% |
| Ghost Tree Capital, LLC | 1,100,000 | $3,641,000 | 0.68% |
| Rhenman & Partners Asset Management AB | 1,282,000 | $4,243,000 | 0.67% |
| Palo Alto Investors LP | 4,254,623 | $14,083,000 | 0.67% |
| NEA Management Company, LLC | 3,243,150 | $10,375,000 | 0.36% |
| Telemetry Investments, L.L.C. | 170,000 | $563,000 | 0.25% |
| NJ State Employees Deferred Compensation Plan | 355,000 | $1,175,000 | 0.22% |